<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="f0e32589-dad9-4887-8481-bcf7f6618466"><labelDrug name="Adenocard"><Normalization/></labelDrug><generic name="adenosine"/><sentence id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.1" text="Drug Label for drug brand Adenocard, containing adenosine." type="negative"><entity charOffset="48:57" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.1.e.0" text="adenosine" type="Biomedical_Entity"><Normalization><mmtx cui="C0001443" phraseText="adenosine." preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.1.e.1" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Adenocard," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.1.e.1" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.1.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.16" lineNumber="24" text="In most instances, these cases were associated with the concomitant use of digoxin and, less frequently with digoxin and verapamil. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.15" Text="Rarely, ventricular fibrillation has been reported following Adenocard administration, including both resuscitated and fatal events. "/><anaphoraEntity charOffset="19:30" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.16.e.1" text="these cases" type="Expression"/><antecedentEntity charOffset="8:32" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.15.e.0" text="ventricular fibrillation" type="SPAN"/></anaphoraRelation><entity charOffset="75:82" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.16.e.0" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="associated with the concomitant use of digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="25:30" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.16.e.3" text="cases" type="Specific_Interaction"/><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.16.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.16.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.15" text="Rarely, ventricular fibrillation has been reported following Adenocard administration, including both resuscitated and fatal events. "><entity charOffset="61:70" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.15.e.1" text="Adenocard" type="Drug"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.16.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.16.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17" lineNumber="24" text="Although no causal relationship or drug-drug interaction has been established, Adenocard should be used with caution in patients receiving digoxin or digoxin and verapamil in combination." type="regular"><entity charOffset="109:116" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.0" text="caution" type="Caution_Interaction"/><entity charOffset="79:88" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.2" text="Adenocard" type="Drug"><Normalization><RxNorm RxCui="258345"/></Normalization></entity><entity charOffset="139:146" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.3" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.3" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.17.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.23" text="Adenocard (adenosine injection) is a respiratory stimulant (probably through activation of carotid body chemoreceptors) and intravenous administration in man has been shown to increase minute ventilation (Ve) and reduce arterial PCO2 causing respiratory alkalosis." type="negative"><entity charOffset="11:20" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.23.e.0" text="adenosine" type="Biomedical_Entity"><Normalization><mmtx cui="C0001443" phraseText="(adenosine injection" preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><entity charOffset="37:58" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.23.e.1" text="respiratory stimulant" type="Biomedical_Entity"><Normalization><mmtx cui="C3536778" phraseText="a respiratory stimulant" preferredWord="Respiratory Stimulant [EPC]" semType="phsu"/><RxNorm RxCui="1025923"/></Normalization></entity><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.23.e.0" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.23.e.1"/></sentence><sentence id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32" text="Intravenous Adenocard (adenosine injection) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile. " type="negative"><entity charOffset="142:173" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.0" text="beta-adrenergic blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="131:140" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.1" text="quinidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0034414" phraseText="such as quinidine," preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="103:121" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.2" text="cardioactive drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0280076" phraseText="administered in the presence of other cardioactive drugs," preferredWord="Cardiac drug" semType="phsu"/><RxNorm RxCui="90873"/></Normalization></entity><entity charOffset="23:32" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.3" text="adenosine" type="Biomedical_Entity"><Normalization><mmtx cui="C0001443" phraseText="(adenosine injection" preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><entity charOffset="212:252" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.4" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="175:206" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.5" text="calcium channel blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0006684" phraseText="calcium channel blocking agents," preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.1" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.0"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.0"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.3" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.0"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.0" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.4"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.0" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.5"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.1"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.3" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.1"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.1" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.4"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.1" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.5"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.3" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.2"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.4"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.5"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.3" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.4"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.3" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.5"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.5" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.32.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33" lineNumber="41" text="Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard (see Warnings ). " type="regular"><entity charOffset="56:80" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.0" text="ventricular fibrillation" type="Specific_Interaction"><Normalization><mmtx cui="C0042510" phraseText="associated with ventricular fibrillation" preferredWord="Ventricular Fibrillation" semType="dsyn"/></Normalization></entity><entity charOffset="100:109" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.2" text="Adenocard" type="Drug"><Normalization><RxNorm RxCui="258345"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.3" text="Digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="Digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="12:21" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil use" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="33:39" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.5" text="rarely" type="SPAN"/><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.2"/></relation><relation type="hasEvidence"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.3" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.2" evidence="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.5" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.4" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.2" evidence="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.5" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.3" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34" lineNumber="41" text="Because of the potential for additive or synergistic depressant effects on the SA and AV nodes, however, Adenocard should be used with caution in the presence of these agents. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33" Text="Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard (see Warnings ). "/><anaphoraEntity charOffset="162:174" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.3" text="these agents" type="Drug"/><antecedentEntity charOffset="0:7" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.3" text="Digoxin" type="Drug"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33" Text="Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard (see Warnings ). "/><anaphoraEntity charOffset="162:174" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.3" text="these agents" type="Drug"/><antecedentEntity charOffset="12:21" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.33.e.4" text="verapamil" type="Drug"/></anaphoraRelation><entity charOffset="29:94" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.0" text="additive or synergistic depressant effects on the SA and AV nodes" type="Specific_Interaction"/><entity charOffset="105:114" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.2" text="Adenocard" type="Drug"><Normalization><RxNorm RxCui="258345"/></Normalization></entity><entity charOffset="162:174" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.3" text="these agents" type="Drug"><Normalization><mmtx cui="C1254351" phraseText="of these agents." preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.3" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.34.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35" lineNumber="41" text="The use of Adenocard in patients receiving digitalis may be rarely associated with ventricular fibrillation (see Warnings )." type="regular"><entity charOffset="11:20" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.0" text="Adenocard" type="Drug"><Normalization><RxNorm RxCui="258345"/></Normalization></entity><entity charOffset="43:52" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.1" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="83:107" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.2" text="ventricular fibrillation" type="Specific_Interaction"><Normalization><mmtx cui="C0042510" phraseText="associated with ventricular fibrillation" preferredWord="Ventricular Fibrillation" semType="dsyn"/></Normalization></entity><entity charOffset="60:66" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.4" text="rarely" type="SPAN"/><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.1"/></relation><relation type="hasEvidence"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.0" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.1" evidence="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.4" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.35.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36" lineNumber="42" text="The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline. " type="regular"><entity charOffset="4:11|25:40" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.0" text="effects are antagonized" type="Decrease_Interaction"/><entity charOffset="15:24" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.2" text="adenosine" type="Drug"><Normalization><mmtx cui="C0001443" phraseText="The effects of adenosine" preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><entity charOffset="44:59" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.3" text="methylxanthines" type="Drug_Class"><Normalization><mmtx cui="C0066447" phraseText="antagonized by methylxanthines" preferredWord="methylxanthine" semType="phsu, orch"/><RxNorm RxCui="29933"/></Normalization></entity><entity charOffset="68:76" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.4" text="caffeine" type="Drug"><Normalization><mmtx cui="C0006644" phraseText="such as caffeine" preferredWord="Caffeine" semType="phsu, orch"/><RxNorm RxCui="236112"/></Normalization></entity><entity charOffset="81:93" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.5" text="theophylline" type="Drug"><Normalization><mmtx cui="C0039771" phraseText="theophylline." preferredWord="Theophylline" semType="bacs, phsu, orch"/><RxNorm RxCui="10438"/></Normalization></entity><drugClassMembership drug="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.4" drugClass="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.3"/><drugClassMembership drug="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.5" drugClass="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.3"/><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.3" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.36.e.0" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37" lineNumber="42" text="In the presence of these methylxanthines, larger doses of adenosine may be required or adenosine may not be effective. " type="regular"><entity charOffset="25:40" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.0" text="methylxanthines" type="Drug_Class"><Normalization><mmtx cui="C0066447" phraseText="of these methylxanthines," preferredWord="methylxanthine" semType="phsu, orch"/><RxNorm RxCui="29933"/></Normalization></entity><entity charOffset="42:54|75:83" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.1" text="larger doses required" type="Decrease_Interaction"/><entity charOffset="58:67" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.3" text="adenosine" type="Drug"><Normalization><mmtx cui="C0001443" phraseText="larger doses of adenosine" preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.0" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.3" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.37.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38" lineNumber="42" text="Adenosine effects are potentiated by dipyridamole. " type="regular"><entity charOffset="10:33" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.0" text="effects are potentiated" type="Increase_Interaction"/><entity charOffset="0:9" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.2" text="Adenosine" type="Drug"><Normalization><mmtx cui="C0001443" phraseText="Adenosine effects" preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><entity charOffset="37:49" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.3" text="dipyridamole" type="Drug"><Normalization><mmtx cui="C0012582" phraseText="potentiated by dipyridamole." preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.0"><relations><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.3" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.38.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39" lineNumber="42" text="Thus, smaller doses of adenosine may be effective in the presence of dipyridamole. " type="regular"><entity charOffset="6:19|40:49" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.0" text="smaller doses effective" type="Increase_Interaction"/><entity charOffset="23:32" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.2" text="adenosine" type="Drug"><Normalization><mmtx cui="C0001443" phraseText="smaller doses of adenosine" preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><entity charOffset="69:81" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.3" text="dipyridamole" type="Drug"><Normalization><mmtx cui="C0012582" phraseText="effective in the presence of dipyridamole." preferredWord="Dipyridamole" semType="phsu, orch"/><RxNorm RxCui="3521"/></Normalization></entity><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.2" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.3" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.39.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41" lineNumber="42" text="As the primary effect of adenosine is to decrease conduction through the A-V node, higher degrees of heart block may be produced in the presence of carbamazepine." type="regular"><entity charOffset="83:112" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.0" text="higher degrees of heart block" type="Specific_Interaction"/><entity charOffset="148:161" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.2" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="produced in the presence of carbamazepine." preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><entity charOffset="25:34" id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.3" text="adenosine" type="Drug"><Normalization><mmtx cui="C0001443" phraseText="of adenosine" preferredWord="Adenosine" semType="phsu, nsba, nnon"/><RxNorm RxCui="296"/></Normalization></entity><drugInteraction id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.ddi.1"><interaction trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.0"><relations><relation type="hasObject"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.3" e2="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.2" trigger="Dailymed.f0e32589-dad9-4887-8481-bcf7f6618466.s.41.e.0" type="Specific_Interaction"/></sentence><positiveExamples number="11"/><negativeExamples number="18"/></document>